VIKING THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.31 USD | +7.91% |
|
+17.17% | +299.30% |
| 25/04 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
| 24/04 | Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours | MT |
Chart calendar Viking Therapeutics, Inc.
c7deadff8ed751247469.cwY4K3zgBTGhPCYY-ZgsbH50P23STRVNUj7EUR-BXOA.PDFfWgmObVP0XRF9vP5hHARECDqnCScCDXitNizWCpEhcQlDE9JaSM1vQQ~d97e10625257d7fce36421d626f3ee0a
Upcoming events on Viking Therapeutics, Inc.
Past events on Viking Therapeutics, Inc.
| 25/04/2024 02:00 am | Q1 2024 Earnings Call |
| 25/04/2024 01:35 am | Q1 2024 Earnings Release |
| 26/03/2024 05:30 pm | VK2735 Phase 1 Trial Results Call |
| 27/02/2024 06:30 pm | VK2735 Phase 2 VENTURE Trial Results Call |
| 13/02/2024 | Oppenheimer Healthcare Life Sciences Conference |
| 08/02/2024 03:00 am | Q4 2023 Earnings Call |
| 08/02/2024 02:35 am | Q4 2023 Earnings Release |
| 28/11/2023 07:15 pm | Evercore ISI HealthCONx Conference |
| 16/11/2023 06:00 pm | Jefferies London Healthcare Conference |
| 15/11/2023 12:20 am | Stifel Healthcare Conference |
| 08/11/2023 | UBS BioPharma Conference |
| 08/11/2023 | Truist Securities BioPharma Symposium |
| 26/10/2023 02:00 am | Q3 2023 Earnings Call |
| 26/10/2023 01:35 am | Q3 2023 Earnings Release |
| 17/10/2023 | Obesity Week Meeting |
| 13/09/2023 05:00 pm | Morgan Stanley Global Healthcare Conference |
| 12/09/2023 10:00 pm | H.C. Wainwright Global Investment Conference |
| 27/07/2023 02:00 am | Q2 2023 Earnings Call |
| 27/07/2023 01:35 am | Q2 2023 Earnings Release |
| 13/06/2023 08:30 pm | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -32,7 -31,9 -2.47% | -42,7 -41,7 -2.31% | -55,7 -57,7 3.5% | 0,00 0,00 - | -101 -100 -0.65% | -141 |
|
EBIT Million USD | Released Forecast Spread | -32,7 -34,7 5.93% | -42,7 -43,5 2.01% | -55,7 -58,0 4.03% | -70,4 -68,3 -2.96% | -101 -99,5 -1.31% | -144 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,8 -29,4 12.27% | -39,5 -39,8 0.67% | -55,0 -57,2 3.91% | -68,9 -67,4 -2.18% | -85,9 -86,9 1.11% | -120 |
|
Net income Million USD | Released Forecast Spread | -25,8 -29,3 12.08% | -39,5 -39,8 0.67% | -55,0 -57,2 3.93% | -68,9 -67,5 -1.97% | -85,9 -86,6 0.85% | -119 |
|
EPS USD | Released Forecast Spread | -0,36 -0,41 11.29% | -0,54 -0,55 1.58% | -0,71 -0,74 3.79% | -0,90 -0,88 -2.62% | -0,91 -0,92 1.52% | -1,12 |
| Announcement Date | 26/02/20 | 17/02/21 | 09/02/22 | 08/02/23 | 07/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -16,2 -13,9 -16.87% | -17,6 -16,6 -6.21% | -16,2 -17,8 9.01% | -20,5 -19,6 -4.86% | -23,7 -21,1 -12.51% | -27,3 -24,3 -12.43% | -29,3 -28,6 -2.4% | -34,1 -29,6 -15.02% | -33,7 | -35,5 | -37,5 | |||
|
EBIT Million USD | Released Forecast Spread | -16,2 -14,9 -8.89% | -17,6 -16,7 -5.55% | -16,2 -18,4 12.02% | -20,3 -18,3 -11.11% | -20,5 -19,4 -5.99% | -23,7 -18,6 -27.92% | -27,3 -23,8 -14.67% | -29,3 -27,9 -4.88% | -34,1 -30,6 -11.32% | -35,1 | -36,6 | -37,8 | -48,2 | -52,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,1 -14,6 -10.48% | -17,4 -16,3 -6.7% | -15,8 -18,0 12.48% | -19,6 -17,9 -9.34% | -19,5 -18,7 -4.34% | -19,2 -17,9 -7.57% | -22,5 -21,7 -3.61% | -24,6 -25,6 3.89% | -27,4 -28,6 4.38% | -29,2 | -30,8 | -32,3 | -38,8 | -43,5 |
|
Net income Million USD | Released Forecast Spread | -16,1 -14,8 -8.75% | -17,4 -16,6 -5.12% | -15,8 -18,1 12.89% | -19,6 -17,9 -9.53% | -19,5 -18,8 -4.04% | -19,2 -18,2 -5.35% | -22,5 -22,0 -2.33% | -24,6 -25,4 3.29% | -27,4 -28,4 3.84% | -28,8 | -30,5 | -31,9 | -38,8 | -43,5 |
|
EPS USD | Released Forecast Spread | -0,21 -0,19 -9.37% | -0,23 -0,21 -8.49% | -0,21 -0,23 9.87% | -0,26 -0,23 -12.07% | -0,25 -0,24 -4.17% | -0,19 -0,19 1.42% | -0,23 -0,22 -4.98% | -0,25 -0,26 1.96% | -0,26 -0,28 8.23% | -0,27 | -0,28 | -0,30 | -0,31 | -0,34 |
| Announcement Date | 27/04/22 | 27/07/22 | 26/10/22 | 08/02/23 | 26/04/23 | 26/07/23 | 25/10/23 | 07/02/24 | 24/04/24 | - | - | - | - | - |
More events
Past sector events for Viking Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VKTX Stock
- Calendar Viking Therapeutics, Inc.
